Oddo BHF downgraded Novo Nordisk (NVO) to Neutral from Outperform with a DKK 465 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Citi opens ‘upside catalyst watch’ on Eli Lilly post selloff
- Novo Nordisk downgraded to Equal Weight from Overweight at Barclays
- Novo Nordisk Stock (NVO) Plunges 20% on Guidance Cut and CEO Appointment
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
- Video: Why JPMorgan Is Defending Eli Lilly Today